| abstract |
FIELD: chemistry. n SUBSTANCE: invention relates to 1-(3-morpholinopropyl)-2-phenylimidazo[1,2-a]benzimidazole dihydrochloride of formula I: n having purine P2Y 1 -receptor antagonist properties, antiaggregant and antithrombotic activity. n EFFECT: obtaining a new compound which can be used in medicine for making a medicinal drug for therapy of diseases accompanied by increase in thrombogenic potential of the blood: atherosclerosis, ischemic heart disease, diabetic angiopathy. n 1 cl, 5 tbl, 1 ex |